Lipella Pharmaceuticals Inc. Common Stock (LIPO) earnings · rev $536.4K
Lipella Pharmaceuticals Inc. Common Stock (LIPO) is a biotechnology company listed on NASDAQ.
This LIPO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported LIPO revenue for 2024-12-31 was $536.4K. Net income was -$5.0M. Revenue was up 19.3% from 2023-12-31 to 2024-12-31. LIPO currently screens at market cap $254.1K.
When the next LIPO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 19.3% from 2023-12-31 to 2024-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full LIPO research stays on the stock page; the tape stays on the quote page.
Not investment advice.